In spite of the silly, and ultimately futile, counter-trend rally we’ve seen for over a week now, there are two sectors are are steadfastly weak, and they’re both related to healthcare. Below are XLV (the healthcare ETF) and IBB (a money-maker for me recently, the biotech ETF).